Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events-Reference-Cited by-同舟云学术

Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events

Published:2007-08 Issue:8 Volume:5 Page:1630-1636
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

BONELLO L.,PAGANELLI F.,ARPIN-BORNET M.,AUQUIER P.,SAMPOL J.,DIGNAT-GEORGE F.,BARRAGAN P.,CAMOIN-JAU L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2007.02609.x/fullpdf

Reference25 articles.

1. A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

2. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting

3. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

4. Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention

5. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Monitoring of Antithrombotic Therapy in Cardiovascular Disease;Cardiovascular Innovations and Applications;2024

2. Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease;Platelets;2023-04-18

3. CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome;Research and Practice in Thrombosis and Haemostasis;2023-02

4. Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease;BMC Cardiovascular Disorders;2022-12-30

5. Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis;BMC Cardiovascular Disorders;2022-03-17